BACKGROUND: Babesia infection is caused by intraerythrocytic tick-borne parasites. Cases of transfusion-transmitted babesiosis have been increasingly recognized. To date, no Babesia test has been licensed for screening US blood donors. We conducted a longitudinal study to assess the course and markers of Babesia infection among seropositive donors identified in a seroprevalence study. STUDY DESIGN AND METHODS: Eligible donors had B. microti indirect fluorescent antibody (IFA) titers of 64 or greater. Enrollees were monitored up to 3 years, by IFA and three methods for evidence of parasitemia: B. microti nested polymerase chain reaction (PCR) analysis (at two laboratories), hamster inoculation, and blood-smear examination. RESULTS: Among 115 eligible donors, 84 (73%) enrolled. Eighteen enrollees (21%) had evidence of parasitemia for 30 total specimens (17% of 181), which were collected in 9 different months and tested positive by various approaches: PCR (25 specimens/16 persons), hamster inoculation (13 specimens/8 persons), and blood smear (one specimen positive by all three approaches). Overall, 14 persons had one or more specimen with positive PCR results at both laboratories (12 persons) and/or had parasitologically confirmed infection (eight persons). Three of nine persons who had more than one specimen with evidence of parasitemia had nonconsecutive positives. Several enrollees likely had been infected at least 1 year when their last positive specimen was collected. The final three specimens for seven persons tested negative by all study methods, including IFA. CONCLUSION: Seropositive blood donors can have protracted low-level parasitemia that is variably and intermittently detected by parasitologic and molecular methods. Donor-screening algorithms should include serologic testing and not solely rely on molecular testing.
BACKGROUND:Babesia infection is caused by intraerythrocytic tick-borne parasites. Cases of transfusion-transmitted babesiosis have been increasingly recognized. To date, no Babesia test has been licensed for screening US blood donors. We conducted a longitudinal study to assess the course and markers of Babesia infection among seropositive donors identified in a seroprevalence study. STUDY DESIGN AND METHODS: Eligible donors had B. microti indirect fluorescent antibody (IFA) titers of 64 or greater. Enrollees were monitored up to 3 years, by IFA and three methods for evidence of parasitemia: B. microti nested polymerase chain reaction (PCR) analysis (at two laboratories), hamster inoculation, and blood-smear examination. RESULTS: Among 115 eligible donors, 84 (73%) enrolled. Eighteen enrollees (21%) had evidence of parasitemia for 30 total specimens (17% of 181), which were collected in 9 different months and tested positive by various approaches: PCR (25 specimens/16 persons), hamster inoculation (13 specimens/8 persons), and blood smear (one specimen positive by all three approaches). Overall, 14 persons had one or more specimen with positive PCR results at both laboratories (12 persons) and/or had parasitologically confirmed infection (eight persons). Three of nine persons who had more than one specimen with evidence of parasitemia had nonconsecutive positives. Several enrollees likely had been infected at least 1 year when their last positive specimen was collected. The final three specimens for seven persons tested negative by all study methods, including IFA. CONCLUSION: Seropositive blood donors can have protracted low-level parasitemia that is variably and intermittently detected by parasitologic and molecular methods. Donor-screening algorithms should include serologic testing and not solely rely on molecular testing.
Authors: Evan M Bloch; Barbara L Herwaldt; David A Leiby; Annette Shaieb; Ross M Herron; Michael Chervenak; William Reed; Robert Hunter; Rosilyn Ryals; Ward Hagar; Maniphet V Xayavong; Susan B Slemenda; Norman J Pieniazek; Patricia P Wilkins; Anne M Kjemtrup Journal: Transfusion Date: 2011-12-13 Impact factor: 3.157
Authors: Laura Tonnetti; Aaron M Thorp; Heather L Reddy; Shawn D Keil; Raymond P Goodrich; David A Leiby Journal: Transfusion Date: 2012-07-13 Impact factor: 3.157
Authors: Barbara L Herwaldt; Jeanne V Linden; Elizabeth Bosserman; Carolyn Young; Danuta Olkowska; Marianna Wilson Journal: Ann Intern Med Date: 2011-09-05 Impact factor: 25.391
Authors: Laura Tonnetti; Melanie C Proctor; Heather L Reddy; Raymond P Goodrich; David A Leiby Journal: Transfusion Date: 2009-12-18 Impact factor: 3.157
Authors: Sanjeev Gumber; Fernanda S Nascimento; Kenneth A Rogers; Henry S Bishop; Hilda N Rivera; Maniphet V Xayavong; Sushil G Devare; Gerald Schochetman; Praveen K Amancha; Yvonne Qvarnstrom; Patricia P Wilkins; François Villinger Journal: Transfusion Date: 2016-02-19 Impact factor: 3.157
Authors: Yong Wang; TaLesa Aderohunmu; Henry Bishop; Isabel McAuliffe; Hilda N Rivera; Darlyne Smith; Patricia P Wilkins; Katherine E Bowden; Matthew S Reed; Pavel Svoboda; Olga Stuchlik; Jan Pohl; Ryan E Wiegand; Sukwan Handali Journal: J Clin Microbiol Date: 2021-08-25 Impact factor: 5.948
Authors: Evan M Bloch; Andrew E Levin; Phillip C Williamson; Sherri Cyrus; Beth H Shaz; Debra Kessler; Jed Gorlin; Roberta Bruhn; Tzong-Hae Lee; Leilani Montalvo; Hany Kamel; Michael P Busch Journal: Transfusion Date: 2016-05-17 Impact factor: 3.157
Authors: Meghan B Brennan; Barbara L Herwaldt; James J Kazmierczak; John W Weiss; Christina L Klein; Catherine P Leith; Rong He; Matthew J Oberley; Laura Tonnetti; Patricia P Wilkins; Gregory M Gauthier Journal: Emerg Infect Dis Date: 2016-11 Impact factor: 6.883
Authors: Kevin Cheng; Kelly E Coller; Christopher C Marohnic; Zachary A Pfeiffer; James R Fino; Randee R Elsing; Janet Bergsma; Marilee A Marcinkus; Alak K Kar; Orlando H Gumbs; Kathy S Otis; Jeffrey Fishpaugh; Phillip W Schultz; Mark R Pope; Alfredo R Narvaez; Susan J Wong; Susan Madison-Antenucci; Thomas P Leary; George J Dawson Journal: J Clin Microbiol Date: 2018-07-26 Impact factor: 5.948
Authors: Andrew E Levin; Phillip C Williamson; Evan M Bloch; Joan Clifford; Sherri Cyrus; Beth H Shaz; Debra Kessler; Jed Gorlin; James L Erwin; Neil X Krueger; Greg V Williams; Oksana Penezina; Sam R Telford; John A Branda; Peter J Krause; Gary P Wormser; Anna M Schotthoefer; Thomas R Fritsche; Michael P Busch Journal: Transfusion Date: 2016-05-25 Impact factor: 3.157